Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.
- DOI
- 10.1016/j.medj.2025.100987
- Published
- 2026 Mar 13
- Container
- Med (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.medj.2025.100987,
title = {Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.},
author = {Dodd KC and Baillie K and Holt JKL and Leite MI and Lin L and West PW and Miller JAL and Spillane J and Viegas S and Zelek WM and Sussman J and Menon M},
year = {2026},
journal = {Med (New York, N.Y.)},
doi = {10.1016/j.medj.2025.100987},
url = {https://doi.org/10.1016/j.medj.2025.100987}
}RIS
TY - JOUR TI - Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis. AU - Dodd KC AU - Baillie K AU - Holt JKL AU - Leite MI AU - Lin L AU - West PW AU - Miller JAL AU - Spillane J AU - Viegas S AU - Zelek WM AU - Sussman J AU - Menon M PY - 2026 JO - Med (New York, N.Y.) DO - 10.1016/j.medj.2025.100987 UR - https://doi.org/10.1016/j.medj.2025.100987 ER -
APA
KC, D., K, B., JKL, H., MI, L., L, L., PW, W., JAL, M., J, S., S, V., WM, Z., J, S., & M, M. (2026). Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.. Med (New York, N.Y.). https://doi.org/10.1016/j.medj.2025.100987
Source records
- pubmed · retrieved 2026-09-27T12:08:41.268Z